Barak Arye Ben's most recent trade in NovoCure Ltd was a trade of 81,499 Stock Options (Right to buy) done . Disclosure was reported to the exchange on March 4, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 173,696 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 14.75 per share. | 31 Dec 2024 | 669 | 118,721 (0%) | 0% | 14.7 | 9,866 | Ordinary Shares |
NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 12.24 per share. | 28 Jun 2024 | 930 | 118,052 (0%) | 0% | 12.2 | 11,383 | Ordinary Shares |
NovoCure Ltd | Ben Arye Barak | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 125,078 | 125,078 | - | - | Stock Options (Right to buy) | |
NovoCure Ltd | Barak Arye Ben | General Counsel | Grant, award, or other acquisition of securities at price $ 16.30 per share. | 27 Feb 2024 | 81,799 | 117,122 (0%) | 0% | 16.3 | 1,333,324 | Ordinary Shares |
NovoCure Ltd | Arye Barak Ben | General Counsel | Grant, award, or other acquisition of securities at price $ 12.69 per share. | 27 Feb 2024 | 128 | 35,323 (0%) | 0% | 12.7 | 1,624 | Ordinary Shares |
NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 35.28 per share. | 30 Jun 2023 | 288 | 35,195 (0%) | 0% | 35.3 | 10,161 | Ordinary Shares |
NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 29,531 | 29,531 | - | - | Ordinary Shares | |
NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 17,755 | 34,907 (0%) | 0% | 0 | Ordinary Shares | |
NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 62.31 per share. | 06 Jan 2023 | 150 | 17,152 (0%) | 0% | 62.3 | 9,346 | Ordinary Shares |
NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 59.08 per share. | 05 Jul 2022 | 144 | 17,002 (0%) | 0% | 59.1 | 8,507 | Ordinary Shares |